Sep 28, 2026 04:05PM
Sep 24, 2026 12:20PM
Sep 24, 2026 07:00AM
Sep 24, 2026 07:00AM
Aug 24, 2026 06:10AM
Aug 24, 2026 03:01AM
Aug 4, 2026 04:05PM Acadia Pharmaceuticals Reports Second Quarter 2026 Financial Results
Jul 30, 2026 05:57PM
Jul 20, 2026 09:05AM
Jul 20, 2026 09:05AM
Jul 15, 2026 04:05PM
Jul 6, 2026 09:04AM
Jun 26, 2026 06:49AM
Jun 26, 2026 06:49AM DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP
May 6, 2026 04:05PM
Apr 30, 2026 04:05PM
Apr 28, 2026 04:05PM
Apr 17, 2026 09:05AM
Apr 15, 2026 04:05PM
Apr 7, 2026 09:08AM
Apr 7, 2026 09:05AM Acadia Pharmaceuticals Announces DAYBUE® STIX (trofinetide) is Now Broadly Available in the United States for the Treatment of Rett Syndrome
Mar 12, 2026 04:05PM
Mar 3, 2026 04:05PM
Mar 3, 2026 04:05PM
Mar 2, 2026 04:56PM
Mar 2, 2026 04:05PM
Mar 2, 2026 04:05PM
Feb 25, 2026 04:05PM Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operating Overview
Feb 23, 2026 04:05PM
Feb 4, 2026 04:05PM
Feb 3, 2026 06:36AM
Feb 2, 2026 04:14PM
Feb 2, 2026 04:05PM
Jan 13, 2026 09:02AM
Jan 13, 2026 09:00AM Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Dec 18, 2025 04:05PM
Dec 12, 2025 08:00AM
Dec 12, 2025 08:00AM
Nov 20, 2025 04:05PM
Nov 16, 2025 03:00PM
Nov 5, 2025 04:05PM
Oct 28, 2025 04:05PM Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Oct 15, 2025 04:05PM
Oct 2, 2025 09:05AM
Oct 2, 2025 09:04AM
Sep 24, 2025 07:00AM
Sep 24, 2025 07:00AM
Sep 12, 2025 04:05PM
Sep 12, 2025 04:05PM Real World Data from LOTUS Study Evaluating Long-term Efficacy and Tolerability Outcomes of DAYBUE® (trofinetide) in Patients with Rett Syndrome Published in Developmental Medicine and Child Neurolog
Sep 11, 2025 08:18AM

334,270 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All